Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia. (2023)

First Author: Schneider P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40164-023-00445-8

PubMed Identifier: 37740239

Publication URI: http://europepmc.org/abstract/MED/37740239

Type: Journal Article/Review

Volume: 12

Parent Publication: Experimental hematology & oncology

Issue: 1

ISSN: 2162-3619